Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALKS
IMVT
Add up to 3 more stocks
ALKS
Alkermes plc
-1.61%
$42.07-0.69Delayed quote: Oct 6, 2026, 12:10 PM EDT
Market Cap
$7.06B
52W Range
$27.00 - $55.67
IMVT
Immunovant, Inc.
-3.07%
$32.23-1.02Delayed quote: Oct 6, 2026, 12:05 PM EDT
Market Cap
$6.65B
52W Range
$15.95 - $45.42
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 109.84 | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.90 | 9.05 |
| P/S Ratio | 4.23 | 937.61 |
| P/FCF Ratio | 31.85 | N/A |
| EV/EBITDA | 45.38 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 84.6% | 0.0% |
| Operating Margin | 17.2% | 0.0% |
| Net Margin | 4.0% | -7585.9% |
| ROE | 3.7% | -73.2% |
| ROA | 1.5% | -63.1% |
| ROIC | 2.1% | -76.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.30 | 7.27 |
| Quick Ratio | 1.85 | 7.27 |
| Debt/Equity | 0.87 | 0.00 |
| Interest Coverage | 20.69 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.